Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis
Xue-Yan Chen, Bing-Xi Yan, Xiao‐Yong Man
Therapeutic Advances in Respiratory Disease (2020) Vol. 14
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

The signal pathways and treatment of cytokine storm in COVID-19
Lan Yang, Xueru Xie, Zikun Tu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 508
The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections
Ren‐Jun Hsu, Wei-Chieh Yu, Guan-Ru Peng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 106
The roles of critical pro‐inflammatory cytokines in the drive of cytokine storm during SARS‐CoV‐2 infection
Muhammad Suhaib Qudus, Mingfu Tian, Summan Sirajuddin, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Open Access | Times Cited: 50
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
Masoumeh Farahani, Zahra Niknam, Leila Mohammadi Amirabad, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112420-112420
Open Access | Times Cited: 102
Could the Induction of Trained Immunity by β-Glucan Serve as a Defense Against COVID-19?
Anne E. Geller, Jun Yan
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 83
Inflammation in Coronary Microvascular Dysfunction
Μarios Sagris, Panagiotis Theofilis, Alexios S. Antonopoulos, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13471-13471
Open Access | Times Cited: 69
Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives
Μarios Sagris, Panagiotis Theofilis, Alexios S. Antonopoulos, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6607-6607
Open Access | Times Cited: 65
A deep learning-based quantitative computed tomography model for predicting the severity of COVID-19: a retrospective study of 196 patients
Weiya Shi, Xueqing Peng, Tiefu Liu, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 3, pp. 216-216
Open Access | Times Cited: 64
Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
Yujie Jiang, Tingmei Zhao, Xueyan Zhou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 46
Drug repurposing and cytokine management in response to COVID-19: A review
Luana Heimfarth, Mairim Russo Serafini, Paulo Ricardo Martins‐Filho, et al.
International Immunopharmacology (2020) Vol. 88, pp. 106947-106947
Open Access | Times Cited: 56
Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial
Atefeh Fakharian, Saghar Barati, Maryam Sadat Mirenayat, et al.
International Immunopharmacology (2021) Vol. 99, pp. 107961-107961
Open Access | Times Cited: 32
High Levels of the Cleaved Form of Galectin-9 and Osteopontin in the Plasma Are Associated with Inflammatory Markers That Reflect the Severity of COVID-19 Pneumonia
Gaowa Bai, Daisuke Furushima, Toshiro Niki, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4978-4978
Open Access | Times Cited: 29
Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm
Xiang Peng, Yani Wang, Xiangwen Xi, et al.
Cardiovascular Drugs and Therapy (2021) Vol. 35, Iss. 2, pp. 231-247
Open Access | Times Cited: 28
N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19
Heidi N. du Preez, Colleen Aldous, Hendrik G. Kruger, et al.
Advances in Pharmacological and Pharmaceutical Sciences (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 21
Pathogenesis of COVID‐19 described through the lens of an undersulfated and degraded epithelial and endothelial glycocalyx
Heidi N. du Preez, Colleen Aldous, Melvin R. Hayden, et al.
The FASEB Journal (2021) Vol. 36, Iss. 1
Open Access | Times Cited: 24
Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?
Μarios Sagris, Panagiotis Theofilis, Alexios Antonopoulos, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 242-242
Open Access | Times Cited: 18
Dysambiol, an Anti-inflammatory Secomeroterpenoid from a Dysidea sp. Marine Sponge
Wei‐Hua Jiao, Jiaxin Li, Hongyan Liu, et al.
Organic Letters (2023) Vol. 25, Iss. 34, pp. 6391-6395
Closed Access | Times Cited: 9
Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C)
Frans A. Kuypers, Christina A. Rostad, Evan J. Anderson, et al.
Experimental Biology and Medicine (2021) Vol. 246, Iss. 23, pp. 2543-2552
Open Access | Times Cited: 20
Prophylactic Effects of Purple Shoot Green Tea on Cytokine Immunomodulation through Scavenging Free Radicals and NO in LPS-Stimulated Macrophages
Chih‐Cheng Lin, Hsiu-Hua Lin, Hsiang Chang, et al.
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 9, pp. 3980-4000
Open Access | Times Cited: 14
Targeting the sAC-Dependent cAMP Pool to Prevent SARS-Cov-2 Infection
Muhammad Aslam, Yury Ladilov
Cells (2020) Vol. 9, Iss. 9, pp. 1962-1962
Open Access | Times Cited: 13
Myeloid dysregulation and therapeutic intervention in COVID-19
Runxia Gu, Tianyang Mao, Lu Qiao, et al.
Seminars in Immunology (2021) Vol. 55, pp. 101524-101524
Open Access | Times Cited: 12
Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques
Hongbo Chen, Zhongping Xie, Runxiang Long, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 23, pp. 108-118
Open Access | Times Cited: 11
The Probable Protective Effect of Photobiomodulation on the Immunologic Factor’s mRNA Expression Level in the Lung: An Extended COVID-19 Preclinical and Clinical Meta-analysis
Babak Arjmand, Fakher Rahim
Clinical Pathology (2023) Vol. 16
Open Access | Times Cited: 4
Pharmacotherapeutics for cytokine storm in COVID-19
Rishi Pal, Manju J. Chaudhary
Elsevier eBooks (2024), pp. 101-125
Closed Access | Times Cited: 1
Computational and Transcriptome Analyses Revealed Preferential Induction of Chemotaxis and Lipid Synthesis by SARS-CoV-2
Hibah Shaath, Nehad M. Alajez
Biology (2020) Vol. 9, Iss. 9, pp. 260-260
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top